Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

Name: Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
Published: 2019
License: Public Domain

St. Jude Children's Research Hospital · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

brain-cancer brain-tumor pediatric

brain tumor, brain tumor, recurrent, brain tumor, refractory, brain tumor, pediatric, medulloblastoma, medulloblastoma recurrent, medulloblastoma, non-wnt/non-shh, medulloblastoma, non-wnt/non-shh, group 3, medulloblastoma, non-wnt/non-shh, group 4, brain cancer, cns cancer, cns tumor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 855026
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.